The present invention relates to the use of N-Methyl-D-aspartate (NMDA) antagonists at sub-anesthetic doses for the treatment of mental disorders with occurrence of aggressive and/or impulsive behavior.
Missal, M. (2015). Nmda antagonists for the treatment of mental disorders with occurrence of aggressive and/or impulsive behavior (Patent No. EP20150164724). https://hdl.handle.net/2078.5/178466